OnabotulinumtoxinA discontinuation in patients with prior nerve stimulation-Reference-Cited by-同舟云学术

OnabotulinumtoxinA discontinuation in patients with prior nerve stimulation

Published:2022-12-26 Issue:2 Volume:42 Page:436-444
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Woodburn Katherine¹^ORCID,Hoang Elizabeth²,Quan Karen³,Pennycuff Jon⁴,Richter Lee A.¹

Affiliation:

1. Section of Female Pelvic Medicine and Reconstructive Surgery, National Center for Advanced Pelvic Surgery Georgetown University/MedStar Washington Hospital Center Washington District of Columbia USA

2. Department of Obstetrics and Gynecology Georgetown University/MedStar Washington Hospital Center Washington District of Columbia USA

3. Georgetown Medical School Georgetown University Washington District of Columbia USA

4. Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery University of Wisconsin School of Medicine and Public Health Madison USA

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.25121

Reference9 articles.

1. Prevalence and burden of overactive bladder in the United States

2. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment

3. Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivity

4. Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms

5. Long-Term Discontinuation of Botulinum Toxin A Intradetrusor Injections for Neurogenic Detrusor Overactivity: A Multicenter Study